Wyszko; Eliza

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wyszko; Eliza.The latest application filed is for "pharmaceutical composition for treating adverse reactions due to administration of spiegelmers".

Company Profile

0.9.8

Wyszko; Eliza - Poznan N/A PL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Importation of a ribozyme into vegetable mitochondria by a pseudo-tRNA that can be aminoacylated by valine Grant 9,441,243 - Dietrich , et al. September 13, 2	2016-09-13
Cytosine analogue, a method of preparation of a cytosine analogue, a DNA methyltransferase 1 inhibitor, a method for DNA methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal DNA methylation Grant 9,040,490 - Barciszewski , et al. May 26, 2	2015-05-26
Pharmaceutical Composition For Treating Adverse Reactions Due To Administration Of Spiegelmers App 20150140020 - Erdmann; Volker A. ; et al.	2015-05-21
Sequence of dsRNA: ATN-RNA specific for tenascin-C Grant 8,946,400 - Barciszewski , et al. February 3, 2	2015-02-03
Pharmaceutical Composition For Treating Adverse Reactions Due To Administration Of Spiegelmers App 20130237591 - Erdmann; Volker A. ; et al.	2013-09-12
Method of obtaining of 4-N-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-N-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition Grant 8,404,660 - Barciszewski , et al. March 26, 2	2013-03-26
Cytosine Analogue, A Method Of Preparation Of A Cytosine Analogue, A Dna Methyltransferase 1 Inhibitor, A Method For Dna Methylation Inhibition, The Use Of The Analogue In The Treatment Of Diseases Associated With Deviations From Normal Dna Methylation App 20120322755 - Barciszewski; Jan ; et al.	2012-12-20
Pharmaceutical Composition For Treating Adverse Reactions Due To Administration Of Spiegelmers App 20120149763 - Erdmann; Volker A. ; et al.	2012-06-14
Importation of a Ribozyme into Vegetable Mitochondria by a Pseudo-tRNA that can be Aminoacylated by Valine App 20110225683 - Dietrich; Andre ; et al.	2011-09-15
Method of manufacturing 3-(4-hydroxyphenyl)propanoic acid amide, its application in the manufacture of anti-aging compositions and anti-aging composition Grant 7,923,578 - Barciszewski , et al. April 12, 2	2011-04-12
Method Of Obtaining Of 4-n-furfurylcytosine And/or Its Derivatives, An Anti-aging Composition And Use Of 4-n-furfurylcytosine And/or Its Derivatives In The Manufacture Of Anti-aging Composition App 20100317612 - Barciszewski; Jan ; et al.	2010-12-16
Sequence Of Dsrna: Atn-rna, Intervention Using Irnai, Use Of A Sequence Of Dsrna: Atn-rna, A Method Of Treating And Inhibiting A Brain Tumor, A Kit For Inhibiting Cancer Cell Which Expresses Tenascin, A Method For A Kit Preparation In A Brain Tumor Therapy App 20100076053 - Barciszewski; Jan ; et al.	2010-03-25
Method of Manufacturing 3-(4-Hydroxyphenyl)Propanoic Acid Amide, Its Application in the Manufacture of Anti-Aging Compositions and Anti-Aging Composition App 20080249334 - Barciszewski; Jan ; et al.	2008-10-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.